How it works for companies
We help companies to
Gain a competitive advantage by identifying cutting-edge innovation and expertise from universities and institutes worldwide.
- Connect with teams actively looking for industry partners
- Benefit from the latest academic breakthroughs
- Spend less time on outreach through scalable scouting
How companies engage through IN-PART
Get matched to new opportunities through Connect for free
Create an interests profile and review matches from 250+ subscribed institutes across all sectors and development stages.
- Saved searches and filters
- Weekly alerts with recommendations from our team
- Only active, available and up-to-date opportunities
Extend your reach through Discover
Proactively engage an embedded network of academics and commercialisation teams in 2,400+ institutes with requirements or requests for proposals.
- An in-house team of STEM experts working for you
- Identify technologies, research, expertise, centres of excellence, and spin-outs
- Undisclosed opportunities and unpublished research
Start new conversations with academic teams
We introduce you directly to the team behind each project.
- Completely free with no associated costs
- Trusted, secure, and confidential
- A direct line to new partners
Create impact with us
Identify opportunities aligned to your priorities
Build connections with institutes worldwide
Drive forward your pipeline with the latest breakthroughs
We help companies create impact
Matching industry decision-makers with the brightest minds in academia to solve real-world problems.
Active Connect Technologies
Light Triggered CRISPR/Cas9 for Spatial and Temporal Control of Genome Editing
The University of North Carolina at Chapel Hill
A novel, light-activated Cas9 proteinfor better special and temporal control of the CRISPR/Cas9 gene editing system
Scaffold-Based Delivery of Cytotoxic Stem Cells for Cancer Therapy
The University of North Carolina at Chapel Hill
A biocompatible scaffold for stem cell delivery, suitable for intracavity use post-tumor resection, and applicable to the treatment of GBMs
Exosomal Drug Delivery for Chemotherapy and CNS Disorders
The University of North Carolina at Chapel Hill
Novel exosome-based compositions for the delivery of low molecular weight active ingredients, drugs and macromolecular biotherapeutics
We work with
Universities
Companies
Testimonials
What our customers say
“I enjoy using IN-PART to easily access academic research from universities across the globe. Different to other providers, IN-PART offers personalised services to screen for early-stage innovation, specific to our research requirements, at a large number of associated universities! And amazingly, they do this free of charge.”
“I really like IN-PART for two reasons. It’s easy to enter, navigate and filter however you want. Secondly, they are consistent, responsive, and they really care what you are looking for and what you need.”
"[IN-PART] has clearly been designed to aid developers and industry to find each other simply without any restrictions or hidden costs. I would like to thank the IN-PART team for the service and will continue to consider technologies forward for our review."